Matthias Schumacher

Leon Nanodrugs

Chief Technology Officer at Leon Nanodrugs GmbH (LEON), a Munich-based pharmaceutical technology company specializing in next-generation lipid nanoparticle manufacturing technologies.

He leads the development of the proprietary FR-JET® platform and LEON’s full equipment portfolio — NANOscreen, NANOlab, NANOme, and NANOus — covering formulation screening, process development, and GMP-compliant aseptic manufacturing across all scales.

With over a decade of R&D experience in drug delivery systems and nanomaterials, he drives the company’s engineering and product development strategy.